Oklahoma City, OKNCT03845036Now EnrollingIRB Ready

Claudication Clinical Trial in Oklahoma City, OK

Access cutting-edge claudication treatment through this clinical trial at a research site in Oklahoma City. Study-provided care at no cost to qualified participants.

Sponsored by University of Oklahoma

Quick Self-Assessment

See if you qualify for this Oklahoma City location

Preparing your pre-screening questions…

Expert Care in Oklahoma City

Access claudication specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related claudication treatment provided free

Apply for This Oklahoma City Location

Check if you qualify for this claudication clinical trial in Oklahoma City, OK

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Oklahoma City

    Convenient for OK residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Oklahoma City site if eligible
  4. 4Begin participation

About This Claudication Study in Oklahoma City

This study is a 3-month, prospective, randomized controlled clinical trial designed to address the efficacy of the DASH dietary program combined with a home-based exercise program, quantified by a step activity monitor, to improve exercise and vascular outcome measures in patients with PAD.

Sponsor: University of Oklahoma

Who Can Participate

Inclusion Criteria

History of claudication,
Presence of PAD, defined by meeting at least one of the following criteria (ABI at rest \< 0.90, or \> 20% decrease in ABI following a heel-rise exercise test in patients with a normal ABI at rest (\> 0.90), or history of peripheral revascularization.

Exclusion Criteria

absence of PAD, defined by meeting all of the following 3 criteria (ABI at rest \> 0.90), \< 20% decrease in ABI following a heel-rise exercise test, and no history of peripheral revascularization,
non-compressible vessels (ABI \> 1.40),
rest pain due to PAD (Fontaine stage III; Rutherford Grade II),
tissue loss due to PAD (Fontaine stage IV; Rutherford Grade III),
use of medications indicated for the treatment of intermittent claudication (cilostazol and pentoxifylline) initiated within three months prior to investigation,
peripheral revascularization within one month prior to investigation,
active cancer,
end stage renal disease defined as stage 5 chronic kidney disease,
medical conditions that are contraindicative for exercise according to the American College of Sports Medicine,
cognitive dysfunction (mini-mental state examination score \< 24), and
failure to complete the baseline tests within three weeks.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Oklahoma City?

Yes, this clinical trial (NCT03845036) has an active research site in Oklahoma City, OK that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Claudication Treatment Options in Oklahoma City, OK

If you're searching for claudication treatment options in Oklahoma City, OK, this clinical trial (NCT03845036) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Oklahoma City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced claudication specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all claudication clinical trials near you to find additional studies recruiting in your area.

More Peripheral Artery Disease Trials in Oklahoma City, OK

See all peripheral artery disease clinical trials recruiting in Oklahoma City — not just this study.

Browse Peripheral Artery Disease Trials in Oklahoma City →

Browse More Trials by Condition

Peripheral Artery Disease TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Oklahoma City?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Oklahoma City, OK